Trial Profile
Phase I/II Intraventricular DepoCyt (OD 06-2348) in Glioblastoma (76,730, 11/06).
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 19 Feb 2019
Price :
$35
*
At a glance
- Drugs Cytarabine (Primary) ; Cytarabine (Primary) ; Temozolomide
- Indications Glioblastoma
- Focus Adverse reactions
- 19 Sep 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 19 Sep 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 11 Feb 2013 Planned End Date changed from 1 Sep 2012 to 1 Sep 2014 as reported by ClinicalTrials.gov.